Health care companies slid as traders retreated from high-risk issues. Shares of obesity-drug maker Novo Nordisk and Hims & Hers Health, the compounding pharmacy seeking to compete with the ...

Novo Nordisk, a Danish pharmaceutical company, has signed a major deal worth up to $2 billion for the rights to a new obesity ...

The two stocks have been trending in different directions for months. Here's what that says about the broader market.

Even after a recent drop in wholesale costs, retail egg prices remain near historic highs, averaging about $6 per dozen — ...

Novo Nordisk is taking aim at Eli Lilly with a new obesity drug deal. Meanwhile, a survey shows doctors’ perception of the ...

[CNBC] ‘Grey’s Anatomy’ star Ellen Pompeo says $20 million salary brings ‘true independence’: ‘I don’t have to do anything I ...

The trial results are critical, as it brings Eli Lilly’s pill one step closer to becoming a new, needle-free alternative for ...

Novo Nordisk (NYSE: NVO) stock slipped 1.7% through 12:10 a.m. ET Monday on a pair of news items with which investors seem ...

Here’s what to do instead to help you stand out and land the role, says Jeremy Schifeling, founder of The Job Insiders and ...

Cotação das ações da empresa alemã de software subiu 40% no último ano, enquanto o fabricante dinamarquês de medicamentos ...

Novo Nordisk agreed to pay up to $2 billion for the rights to a developmental weight-loss and obesity drug from Chinese pharmaceutical company The United Bio-Technology Co., as it looks to boost its ...